Kuros Biosciences AG (LON:0RHR)

Market Cap	808.99M +24.8%
Revenue (ttm)	108.52M +71.5%
Net Income	1.90M
EPS	0.05
Shares Out	n/a
PE Ratio	426.82
Forward PE	86.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,260
Average Volume	14,948
Open	22.59
Previous Close	22.54
Day's Range	21.86 - 22.59
52-Week Range	15.70 - 34.08
Beta	0.63
RSI	34.67
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone graft...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 178
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RHR

Financial Performance

Financial numbers in USD